Publication dates

Cancer Immunotherapy Industry, October 2014 Market Research & Statistics

You might be interested in: vaccine, life sciences, medicine, more »

1-10 of about 400 reports for Cancer Immunotherapy

Pathology Industry - Investor Report, April 2014

  • Innovative Science Affordable Medicine
  • April 2014
    48 pages
  • Insulin  

    Biosimilars  

  • India  

    World  

View report >

Pathology Description in the US - Forecast

  • In this Issue
  • January 2013
    17 pages
  • Cancer  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Pathology Description in the US - Forecast

  • Umbrella Research
  • January 2012
    33 pages
  • Cancer  

    Crohn's Disease  

  • United States  

View report >

Takara Holdings Incorporated - Annual Report, 2013

  • Excellence, Future of Innovation
  • January 2013
    68 pages
  • Japan  

View report >

Bms - Annual Report, 2012

  • 2012 Annual Report
  • January 2012
    104 pages
  • United States  

View report >

Bms - Annual Report, 2012

  • 2012 Annual Report
  • January 2012
    104 pages
  • United States  

View report >

Pathology Description in the US - Forecast

  • Introduction: Oncology Special Edition
  • January 2013
    15 pages
  • Cancer  

  • United States  

View report >

Medicine Markets in the US

  • The Use of Medicines in the United States: Review of 2011
  • April 2012
    46 pages
  • Medicine  

  • United States  

View report >

Medigene - Annual Report, 2013

  • Tr Ansformation
  • January 2013
    145 pages
  • Germany  

View report >
30 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 250 - $ 6 813)

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

Cancer Immunotherapy: immune checkpoint inhibitors, cancer vaccines, and adoptive T-cell therapies

  • $ 2 495
  • Industry report
  • September 2014
  • by CHI Insight Pharma Reports

This report focuses on the rising potential for the newest and most promising of cancer treatments: cancer immunotherapy. Cancer immunotherapy was once just a dream in the minds of physicians, clinicians ...



ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.